A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients
Clinical trial NCT04056442 · COMPLETED
Trial details
- NCT number
- NCT04056442
- Sponsor
- Stero Biotechs Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-07
- Primary completion
- 2022-11-07
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.